Beryllium (CED0000029)

Record Information
Version1.0
Creation Date2009-03-06 18:57:58 UTC
Update Date2026-04-06 04:29:59 UTC
Accession NumberCHEM000038
Identification
Common NameBeryllium
ClassSmall Molecule
Description
Beryllium (Be) is an inorganic compound with an average molecular weight of 9.01 g/mol. Beryllium belongs to the homogeneous alkaline earth metal compounds, a class of homogeneous metal compounds within the inorganic compounds. At room temperature, this exogenous substance exists as a solid. It is utilized as a surface modifier in industrial applications and serves as an adjuvant. Biologically, it acts as a carcinogenic agent and an epitope. Beryllium is found in or released from ten recorded sources, including coins, non-electric simulated smoking devices, and food contact materials. It is also present in building and construction materials such as stairs, ramps, and ceilings, as well as electrical and electronic equipment including amplifiers, antennas, X-ray tubes, radio transmission systems, and adjustable resistors. Exposure routes include touch, oral, and inhalation. It has not been detected in polyethylene terephthalate. Once in the body, beryllium acts as a hapten and interacts with human leucocyte antigen (HLA) DP presenting cells in the lungs, becoming physically associated with a major histocompatability (MHC) class II molecule. This MHC class II-beryllium-peptide complex is recognized by the T lymphocyte receptor, triggering CD4+ T lymphocyte activation and proliferation. The resulting inflammatory response is a cell-mediated process orchestrated by cytokines and results in the formation of (usually pulmona.
Contaminant Type
  • Beryllium Compound
  • Cigarette Toxin
  • Food Toxin
  • Industrial/Workplace Toxin
  • Inorganic Compound
  • Metabolite
  • Metal
  • Natural Compound
  • Pollutant
Chemical Structure
Synonyms
ValueSource
Be(2+)ChEBI
BeHMDB
Beryllium atomHMDB
Beryllium elementHMDB
Beryllium metallicumHMDB
Beryllium-9HMDB
GluciniumHMDB
GlucinumHMDB
Chemical FormulaBe
Average Molecular Mass9.012 g/mol
Monoisotopic Mass9.012 g/mol
CAS Registry Number7440-41-7
IUPAC Nameberyllium(2+) ion
Traditional Nameberyllium(2+) ion
SMILES[Be++]
InChI IdentifierInChI=1S/Be/q+2
InChI KeyPWOSZCQLSAMRQW-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of inorganic compounds known as homogeneous alkaline earth metal compounds. These are inorganic compounds containing only metal atoms,with the largest atom being a alkaline earth metal atom.
KingdomInorganic compounds
Super ClassHomogeneous metal compounds
ClassHomogeneous alkaline earth metal compounds
Sub ClassNot Available
Direct ParentHomogeneous alkaline earth metal compounds
Alternative ParentsNot Available
Substituents
  • Homogeneous alkaline earth metal
Molecular FrameworkNot Available
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Cytoplasm
  • Extracellular
Biofluid LocationsNot Available
Tissue LocationsNot Available
Applications
Biological Roles
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateSolid
AppearanceGrey metallic solid.
Experimental Properties
PropertyValue
Melting Point1300°C
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
logP0ChemAxon
Physiological Charge2ChemAxon
Hydrogen Acceptor Count0ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area0 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity0 m³·mol⁻¹ChemAxon
Polarizability1.78 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Spectra
SpectraNot Available
Toxicity Profile
Mechanism of ToxicityOnce in the body, beryllium acts as a hapten and interacts with human leucocyte antigen (HLA) DP presenting cells in the lungs, becoming physically associated with a major histocompatability (MHC) class II molecule. This MHC class II-beryllium-peptide complex is recognized by the T lymphocyte receptor, triggering CD4+ T lymphocyte activation and proliferation. The resulting inflammatory response is a cell-mediated process orchestrated by cytokines and results in the formation of (usually pulmonary) granulomas. Beryllium's toxicity may be controlled by the iron-storage protein ferritin, which sequesters beryllium by binding it and preventing it from interacting with other enzymes. (7, 1, 2)
Carcinogenicity (IARC Classification)1, carcinogenic to humans. (9)
Minimum Risk LevelChronic Oral: 0.002 mg/kg/day (8)
SymptomsChronic beryllium disease causes fatigue, weakness, difficulty breathing, and a persistent dry cough. (6, 7)
TreatmentChronic beryllium disease is treated with immunosuppressive medicines, usually of the glucocorticoid class. (6)
Toxicity ValuesNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
494Food contact materialsFood, food processing & cookwareNot Available
495CeilingsBuilding & ConstructionNot Available
500Stairs And RampsBuilding & ConstructionNot Available
504Adjustable ResistorsElectrical & Electronic EquipmentNot Available
505AmplifiersElectrical & Electronic EquipmentNot Available
506AntennasElectrical & Electronic EquipmentNot Available
530Radio Transmission SystemsElectrical & Electronic EquipmentNot Available
540X Ray TubesElectrical & Electronic EquipmentNot Available
559Non Electric Simulated Smoking DevicesHousehold cleaning & consumer productsNot Available
571CoinsHousehold itemsNot Available
579Manufacture Of Iron Or SteelIndustrial manufacturing & chemical processingNot Available
592Marine Propulsion Or SteeringMarine, shipping & aquacultureNot Available
Pathways
0 pathways

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
No targets found for this compound.
Concentrations
Not Available
External Links
DrugBank IDNot Available
HMDB IDHMDB0002387
FooDB IDFDB022990
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB ID0BE
Wikipedia LinkBeryllium
Chemspider ID96830
ChEBI ID30502
PubChem Compound ID107649
Kegg Compound IDC16460
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSLink
General References
1. Kreiss K, Day GA, Schuler CR: Beryllium: a modern industrial hazard. Annu Rev Public Health. 2007;28:259-77.
2. Amicosante M, Fontenot AP: T cell recognition in chronic beryllium disease. Clin Immunol. 2006 Nov;121(2):134-43. Epub 2006 May 12.
3. Day GA, Stefaniak AB, Weston A, Tinkle SS: Beryllium exposure: dermal and immunological considerations. Int Arch Occup Environ Health. 2006 Feb;79(2):161-4. Epub 2005 Oct 18.